Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Cibus Global, Ltd.
  6. Summary
    CBUS   US17164W1053

CIBUS GLOBAL, LTD.

(CBUS)
End-of-day quote Nasdaq  - 
- USD   -.--%
01/17Cibus Global, Ltd. entered into a definitive merger agreement to acquire Calyxt, Inc. (NasdaqCM:CLXT) from Cellectis S.A. (ENXTPA:ALCLS) and others in a reverse merger transaction.
CI
2019Cibus Global, Ltd. has withdrawn its IPO in the amount of $106.666672 million.
CI
2018Cibus Global, Ltd. has filed an IPO in the amount of $100 million.
CI
 SummaryQuotesNewsCompanyFunds 
Company
Cibus Global, Ltd. is a United States-based biotechnology company. The Company is a pioneering precision gene editing with versatile Rapid Trait Development System (RTDSTM) to transform the food and agriculture industries. It develops Traits for agricultural crops that are indistinguishable from both Traits developed from traditional breeding or from nature. It's input traits are characteristics in plants that... 
Sector
Fishing & Farming
Calendar
-
More about the company
All news about CIBUS GLOBAL, LTD.
01/17Cibus Global, Ltd. entered into a definitive merger..
CI
2019Cibus Global, Ltd. has withdrawn its IPO in the amount of $106.666672 million.
CI
2018Cibus Global, Ltd. has filed an IPO in the amount of $100 million.
CI
More news
News in other languages on CIBUS GLOBAL, LTD.

- No features available -

More news
Managers and Directors
Rory Balfour Riggs Chairman & Chief Executive Officer
Peter Beetham President, Chief Operating Officer & Director
Greg Gocal Senior Vice President-Research & Development
Mark Lu Director
Eugene Linden Director
Sector and Competitors